Theta Burst for Cognitive Remediation in Schizophrenia: A Case Series and Feasibility Study

Gopalkumar Rakesh, Nicholas A. Mischel, Bruce Luber, Richard S.E. Keefe, Sara Emory, Sarah H. Lisanby, Steven T. Szabo

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)72-74
Number of pages3
JournalJournal of ECT
Issue number1
StatePublished - Mar 1 2020

Bibliographical note

Funding Information:
This work was supported by funding from the National Institute of Mental Health (R21 MH109873 for R.S.E.K. and Department of Veteran Affairs (IK2 CX001397 for S.T.S.). S.H.L. and B.L. are employed by the National Institutes of Health. The views expressed are the authors' own and do not necessarily represent the views of the National Institutes of Health or the United States Government. S.T.S. has served on advisory boards and as a consultant speaker for Jazz Pharmaceuticals, Neurocrine Biosciences, Teva Pharmaceutical Industries Ltd, and Otsuka/Lundbeck Pharmaceuticals. R.S.E.K. currently or in the past 12 months has received honoraria and served as a consultant, speaker, or advisory board member for Abbott Labs, Abide Therapeutics, Acadia, Aeglea Bio Therapeutics, Akili Interactive Labs, Alkermes, Allergan, Aptinyx, Armagen, Astellas, Avanir, Axovant Sciences, Biogen, Biomimetix, Boehringer-Ingelheim, Composite Type, Critical Path Institute, Gammon, Howard & Zeszotarski, Idorsia, Intra-Cellular Therapies, Janssen, JCR, Karuna, Kempharm (DCRI), LSK Global, Lundbeck, Lysogene, Mentis Cura, Montana State University, New York State Office of Mental Health, Otsuka, Parexel, Percept Solutions, Pharm-Olam, Regenxbio, Renuron, Roche, Sangamo, Science 37, Six Degrees Medical, SOBI, Sunovion, Takeda, Teague, Rotenstreich, Stanaland, Fox & Holt, Thrombosis Research Institute, and Wilson Therapeutics. He also receives royalties from versions of the BAC testing battery, the MATRICS Battery (BACS Symbol Coding), and the Virtual Reality Functional Capacity Assessment Tool. He is a shareholder in VeraSci and Sengenix. S.H.L. is listed as coinventor on a transcra-nial magnetic stimulation coil design, with no remuneration. G.R. and N.A.M. are co-first authors. None of the other authors have any conflicts of interest to disclose.

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Psychiatry and Mental health


Dive into the research topics of 'Theta Burst for Cognitive Remediation in Schizophrenia: A Case Series and Feasibility Study'. Together they form a unique fingerprint.

Cite this